Association of liver fibrosis‐4 index with adverse outcomes in hypertrophic cardiomyopathy patients

Association of liver fibrosis‐4 index with adverse outcomes in hypertrophic cardiomyopathy patients

Abstract Aims The fibrosis‐4 index (FIB‐4) is a non‐invasive tool to assess fibrosis risk in chronic liver disease. We aimed to explore the relationship between the FIB‐4 index and long‐term major adverse cardiovascular events (MACE) in HCM patients. Methods and results Consecutive patients diagnose...

Full description

Saved in:
Bibliographic Details
Main Authors: Fuad A. Abdu, Redhwan M. Mareai, Lanqing Xiang, Jassur. Galip, Abdul‐Quddus Mohammed, Wen Zhang, Lu Liu, Chunyue Wang, Ayman A. Mohammed, Guoqing Yin, Xian Lv, Yawei Xu, Wenliang Che
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:ESC Heart Failure
Subjects:
Fibrosis‐4 index
Hypertrophic cardiomyopathy
Liver fibrosis
Prognosis
Online Access:https://doi.org/10.1002/ehf2.14977
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ehf2.14977

Similar Items